Episode 2: Why direct-to-patient access is ready for prime time

Dr. Paul Burton, Chief Medical Officer at Amgen, discusses why direct-to-patient models are becoming a bigger part of the future of pharma access. The conversation explores how patient education, real-world insight and advances in AI could reshape everything from prescription adherence to drug discovery. For more content like this, including panel discussions, articles, in-depth reports & more, check out our Pharma Insights Hub: https://events.reutersevents.com/phar... Don’t miss out - join thousands of pharma leaders who read our monthly Pharma Insights email newsletter here: https://1.reutersevents.com/lp=39080?...